EL
ELI LILLY + CO
LLY· Health Care· PharmaceuticalsS&P 500
Close · 12/10/2026
1,182.62
1D
+0.28%52-week range
783.85 – 1292.65
Volume
12,52,000.00
Price history
LLY
11/09/2026 to 12/10/2026
O 1,181.24 H 1,188.70 L 1,172.81
1W+3.46%
1M+6.00%
3M+2.61%
6M+27.23%
1Y+38.26%
3Y+118.41%
5Y+425.96%
MAX+342.66%
Fundamentals
as of 12/10/2026- Market cap
- $1.11T
- Shares out
- 941.36M
- P/E (trailing)
- 41.68
- P/E (forward)
- 24.75
- EPS (trailing)
- 28.37
- Dividend yield
- 0.57%
- Beta
- 0.45
- Profit margin
- 33.53%
- P/B
- 32.86
- Return on equity
- 78.84%
SEC financial statements
63 quarterly and 19 annual periods through 30/06/2026.
Details
- Ticker
- LLY
- Index
- SP500
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- -
Last close 12/10/2026.
Tracked by Congress
34 filers · 4 on watchlist · 55 buys · 65 sells · ?: 14 · R: 30 · D: 74 · I: 2
- 21/11/2025John BoozmanWSell+Eli Lilly and Company$1,001–$15,000
- 01/07/2026Michael RulliSellEli Lilly and Company Common Stock$1,001–$15,000
- 02/01/2026Michael RulliBuyEli Lilly and Company Common Stock$1,001–$15,000
- 02/12/2025Michael RulliSellEli Lilly and Company Common Stock$1,001–$15,000
- 15/04/2025Thomas H TubervilleWSellEli Lilly and Company$15,001–$50,000
- 27/03/2026Alan ArmstrongSellEli Lilly and Company Common Stock$1,001–$15,000
- 10/07/2026Dan NewhouseSell+Eli Lilly and Company Common Stock$1,001–$15,000
- 10/06/2026Gilbert CisnerosBuyEli Lilly and Company Common Stock$50,001–$100,000